Nucleus, a NYC-based clinical genetic testing and analysis startup, raised a $14 million Series A, CEO Kian Sadeghi tells Axios exclusively.
Why it matters: While the genetic testing space has been troubled of late, there's investor vigor for personalized, functional medicine and whole-body testing.
